Not applicableUnknownNCT04917276What this trial is testingTreatment Response Prediction System of mCRC Patients Based on CTCWho this might be right forColorectal Cancer Stage IVCirculating Tumor Cell Fudan University 100
Testing effectiveness (Phase 2)UnknownNCT02624726What this trial is testingTrial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line TreatmentWho this might be right forMetastatic Colorectal Cancer Hellenic Oncology Research Group 31
Early research (Phase 1)Study completedNCT00940758What this trial is testingPhase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base TherapyWho this might be right forMetastatic Colorectal Cancer PharmaEngine 18
Testing effectiveness (Phase 2)Looking for participantsNCT05310643What this trial is testingNivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRCWho this might be right forMetastatic Colorectal Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 30
Not applicableUnknownNCT04230018What this trial is testingThe Gene Profiles of Primary and Heterogeneous Metastases of Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Sun Yat-sen University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337551What this trial is testingGossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC PositiveWho this might be right forPatients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment Guiying Wang 20
Testing effectiveness (Phase 2)Study completedNCT05025631What this trial is testingA Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）Who this might be right forColorectal Cancer Zhen-Yu Ding 29
Testing effectiveness (Phase 2)Study completedNCT03365882What this trial is testingS1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by SurgeryWho this might be right forColon AdenocarcinomaERBB2 Gene AmplificationRectal Adenocarcinoma+16 more SWOG Cancer Research Network 240
Testing effectiveness (Phase 2)Study completedNCT03517618What this trial is testingTS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRCWho this might be right forMetastatic Colorectal Cancer TTY Biopharm 41
Early research (Phase 1)Study completedNCT03305913What this trial is testingRegorafenib in Combination With TAS-102 in Subjects With Metastatic Colorectal Cancer Who Have Progressed After Standard TherapyWho this might be right forPretreated Metastatic Colorectal Cancer AIO-Studien-gGmbH 12
Testing effectiveness (Phase 2)Study completedNCT02246049What this trial is testingA Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRCWho this might be right forColorectal Neoplasms EPS Corporation 69
Large-scale testing (Phase 3)UnknownNCT02893540What this trial is testingMetronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCWho this might be right forColorectal Cancer Ruijin Hospital 250
Not applicableLooking for participantsNCT07283575What this trial is testingUsing ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)Who this might be right forMetastatic Colorectal Cancer ctDNA Surveillance Fudan University 497
Testing effectiveness (Phase 2)UnknownNCT05970705What this trial is testingRegorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRCWho this might be right forMetastatic Colorectal Cancer Fudan University 101
Testing effectiveness (Phase 2)Study completedNCT02469480What this trial is testingIntravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.Who this might be right forMetastatic Colorectal Cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 64
Testing effectiveness (Phase 2)UnknownNCT05438108What this trial is testingSBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRCWho this might be right forMetastatic Colorectal Cancer Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Study completedNCT03279289What this trial is testingStudy to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based RegimenWho this might be right forMetastatic Colorectal Cancer Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 170
Testing effectiveness (Phase 2)Ended earlyNCT01925274What this trial is testingPF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Pfizer 19
Not applicableStudy completedNCT01811108What this trial is testingAssessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Hellenic Oncology Research Group 670
Not applicableStudy completedNCT04482608What this trial is testingThe mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and SurvivalWho this might be right forColorectal Cancer MetastaticMismatch Repair DeficiencyMicrosatellite Instability High Sun Yat-sen University 671